Lilly, States Quarrel Over Zyprexa Discovery
Eli Lilly & Co. has traded shots with six states over motions for sanctions and allegations of failure to meet discovery obligations in the multidistrict litigation over the anti-psychotic Zyprexa....To view the full article, register now.
Already a subscriber? Click here to view full article